Prevalensi dan determinan kepatuhan konsumsi obat pada penderita hipertensi: studi cross-sectional

Authors

  • Achmad Rifai Program Studi Kesehatan Masyarakat, Institut Kesehatan Medistra Lubuk Pakam
  • Felix Kasim Program Studi Kesehatan Masyarakat, Institut Kesehatan Medistra Lubuk Pakam
  • Fadlilah Widyaningsih Program Studi Kesehatan Masyarakat, Institut Kesehatan Medistra Lubuk Pakam
  • Harris Rambey Program Studi Kesehatan Masyarakat, Institut Kesehatan Medistra Lubuk Pakam
  • Sri Melda Br Bangun Program Studi Kesehatan Masyarakat, Institut Kesehatan Medistra Lubuk Pakam
  • Restutri Indriani Program Studi Kesehatan Masyarakat, Institut Kesehatan Medistra Lubuk Pakam

DOI:

https://doi.org/10.62290/hjph.v2i3.56

Keywords:

kepatuhan, konsumsi obat, hipertensi, pengetahuan, dukungan keluarga

Abstract

Latar belakang: Rendahnya kepatuhan dalam mengonsumsi obat antihipertensi menjadi hambatan bagi keberhasilan pengendalian tekanan darah, serta berkontribusi pada peningkatan risiko komplikasi kardiovaskular dan beban pelayanan kesehatan. Penelitian ini bertujuan untuk mengidentifikasi determinan kepatuhan konsumsi obat pada penderita hipertensi.

Metode: Studi ini menggunakan desain potong lintang (cross-sectional). Populasi penelitian mencakup seluruh pasien hipertensi yang berobat di Puskesmas Klinik Pratama Polkes 01.10.02 Lubuk Pakam pada tahun 2025, dengan jumlah 95 orang. Seluruh populasi dijadikan sampel penelitian melalui teknik total sampling. Pengumpulan data dilakukan menggunakan kuesioner yang disebarkan kepada pasien hipertensi, sedangkan analisis data dilakukan dengan uji Chi-Square pada tingkat signifikansi α = 0,05.

Hasil: Sebanyak 65,3% responden diketahui tidak patuh dalam mengonsumsi obat, sedangkan 34,7% responden patuh dalam konsumsi obat. Faktor-faktor seperti tingkat pendidikan yang rendah, pengetahuan yang kurang, jarak tempat tinggal ≥1 km, minimnya dukungan keluarga, lama konsumsi obat, serta tidak adanya paparan edukasi kesehatan terbukti berhubungan signifikan dengan kepatuhan konsumsi obat.

Kesimpulan: Kepatuhan konsumsi obat pada penderita hipertensi dapat dipengaruhi oleh aspek pendidikan, pengetahuan, jarak tempat tinggal, dukungan keluarga, durasi konsumsi obat, dan edukasi kesehatan.

References

Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension. 2022;79(1):e1–14.

Lu Y, Lan T. Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019. BMC Public Health. 2022;22(1):841.

Lee EKP, Poon P, Yip BHK, Bo Y, Zhu M, Yu C, et al. Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: a meta‐analysis involving 27 million patients. J Am Heart Assoc. 2022;11(17):e026582.

Nguyen TN, Chow CK. Global and national high blood pressure burden and control. Lancet. 2021;398(10304):932–3.

WHO. Hypertension [Internet]. 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension

Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80.

Kemenkes. Survei Kesehatan Indonesia (SKI). 2023.

Feng Y, Zhao Y, Yang X, Li Y, Han M, Qie R, et al. Adherence to antihypertensive medication and cardiovascular disease events in hypertensive patients: a dose–response meta-analysis of 2 769 700 participants in cohort study. QJM An Int J Med. 2022;115(5):279–86.

Albasri A, Hattle M, Koshiaris C, Dunnigan A, Paxton B, Fox SE, et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. bmj. 2021;372.

Setiadi AP, Febriandini A, Trinanda E, Aryaguna W, Chusna IM, Nurlaili Y, et al. Knowing the gap: medication use, adherence and blood pressure control among patients with hypertension in Indonesian primary care settings. PeerJ. 2022;10:e13171.

Goudarzi H, Barati M, Bashirian S, Moeini B. Determinants of medication adherence among hypertensive patients using the Pender’s health promotion model. J Educ Health Promot [Internet]. 2020; 9 (1): 89. 2020.

Khan MU, Shah S, Hameed T. Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland. J Pharm Bioallied Sci. 2014;6(2):104–8.

Insani WN, Wei L, Abdulah R, Alfian SD, Ramadhani NA, Andhika R, et al. Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study. Int J Clin Pharm. 2025;47(2):354–64.

Ayodapo AO, Elegbede OT, Omosanya OE, Monsudi KF. Patient education and medication adherence among hypertensives in a tertiary hospital, South Western Nigeria. Ethiop J Health Sci. 2020;30(2).

Peng X, Wan L, Yu B, Zhang J. The link between adherence to antihypertensive medications and mortality rates in patients with hypertension: a systematic review and meta-analysis of cohort studies. BMC Cardiovasc Disord. 2025;25(1):145.

Guo A, Jin H, Mao J, Zhu W, Zhou Y, Ge X, et al. Impact of health literacy and social support on medication adherence in patients with hypertension: a cross-sectional community-based study. BMC Cardiovasc Disord. 2023;23(1):93.

Edward A, Campbell B, Manase F, Appel LJ. Patient and healthcare provider perspectives on adherence with antihypertensive medications: an exploratory qualitative study in Tanzania. BMC Health Serv Res. 2021;21(1):834.

Shiraly R, Khani Jeihooni A, Bakhshizadeh Shirazi R. Perception of risk of hypertension related complications and adherence to antihypertensive drugs: a primary healthcare based cross-sectional study. BMC Prim Care. 2022;23(1):303.

Pristianty L, Hingis ES, Priyandani Y, Rahem A. Relationship between knowledge and adherence to hypertension treatment. J Public Health Africa. 2023;14(Suppl 1):2502.

Al-Hazmi AH, Alanazi ADM, Thirunavukkarasu A, Alriwely NS, Alrais MMF, Alruwaili ABS, et al. Evaluation of hypertension knowledge and its association with medication adherence among hypertensive patients attending primary health centers: a cross-sectional study from eastern Saudi Arabia. Front Public Heal. 2025;12:1378561.

Siregar PP. Access to Health Services Affects the Level of Adherence to Taking Medication for Hypertensive Patients At Puskesmas Medan Area Selatan Year 2024. Bul Farmatera. 2024;9(2):38–46.

Shahin W, Kennedy GA, Stupans I. The association between social support and medication adherence in patients with hypertension: A systematic review. Pharm Pract. 2021;19(2).

Susanto A, Purwantiningrum H, Saff MMJA. The Information on Exposure and Duration of Suffering with Medication Compliance in Patients of Hypertension. Wind Heal J Kesehat. 2023;227–36.

Pham ST, Dang YTN, Vo T V, Tran HY, Nguyen T. Medication use and adherence in patients with hypertension: a prospective study in Vietnam. J Heal Sci Med Res. 2023;41(5):2023956.

Mustara M, Hartono H, Pamungkasari EP. Key contents of health education and their impact on improving medication adherence among hypertensive patients: A systematic review and meta-analysis. Narra J. 2025;5(2):e2080–e2080.

Ainiyah N, Zahroh C, Kusumawati DR, Damawiyah S, Wardani EM. Cross sectional study: health literacy towards adherence to medication for hypertension patients. Bali Med J. 2023;12(3):2917–21.

Published

2025-07-31

Issue

Section

Original Article